Advocacy
Learn more about the Association's advocacy efforts to ensure patient
access to therapies.
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0acaf27b0a4de4c33_resources-hero_cell1.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809af6100c642491b1144_resources-hero_cell2.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c9a071f3e1315c44_resources-hero_cell3.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809aff7e7c55068ea25b5_resources-hero_cell4.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0c077d95e001f56d8_resources-hero_cell5.webp)
![](https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/63c809b0a95ec247802ff9ad_resources-hero_cell6.webp)
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Apr 12, 2022
Letter to the New York State Department of Health Commissioner: New York’s Clinical Laboratory Regulations
The Plasma Protein Therapeutics Association (PPTA) is writing to request that you please consider expeditiously granting a reasonable and necessary regulatory reform for the SourcePlasma sector pertaining to two of New York’s clinical laboratory regulations.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f64c2490bcf9502656fc_Letter_to_NYDOH_Commissioner.pdf
Apr 12, 2022
Letter to the New York State Department of Health Commissioner: New York’s Clinical Laboratory Regulations
The Plasma Protein Therapeutics Association (PPTA) is writing to request that you please consider expeditiously granting a reasonable and necessary regulatory reform for the SourcePlasma sector pertaining to two of New York’s clinical laboratory regulations.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f64c2490bcf9502656fc_Letter_to_NYDOH_Commissioner.pdf
Oct 1, 2021
Together toward a broader European plasma donation ecosystem
Strengthening the EU Blood Directive: To meet the needs of patients using plasma-derived medicinal products and plasma donors
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f652d7ca1569557512dc_PPTA%20Position%20Paper%20on%20the%20EU%20BTC%20revision_September2021.pdf
Oct 1, 2021
Together toward a broader European plasma donation ecosystem
Strengthening the EU Blood Directive: To meet the needs of patients using plasma-derived medicinal products and plasma donors
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f652d7ca1569557512dc_PPTA%20Position%20Paper%20on%20the%20EU%20BTC%20revision_September2021.pdf
Jul 13, 2021
Europe Needs to Collect More Plasma
Plasma-derived medicinal products PDMPs), derived from human plasma from healthy donors, are essential for around 300,000 European patients who rely on these therapies to treat a variety of rare, chronic, and potentially life-threatening conditions, which are often genetic in origin.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64539bb0b145bb5b857f53a7_EU%20Position%20paper_Europe%20needs%20to%20collect%20more%20plasma.pdf
Jul 13, 2021
Europe Needs to Collect More Plasma
Plasma-derived medicinal products PDMPs), derived from human plasma from healthy donors, are essential for around 300,000 European patients who rely on these therapies to treat a variety of rare, chronic, and potentially life-threatening conditions, which are often genetic in origin.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/64539bb0b145bb5b857f53a7_EU%20Position%20paper_Europe%20needs%20to%20collect%20more%20plasma.pdf
Mar 31, 2021
PPTA Supports California AB 392
The Plasma Protein Therapeutics Association (PPTA) would like to thank you for authoring Assembly Bill 392.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f688a121567c7026889d_PPTA%20Supports%20AB%20392%20Nazarian.pdf
Mar 31, 2021
PPTA Supports California AB 392
The Plasma Protein Therapeutics Association (PPTA) would like to thank you for authoring Assembly Bill 392.
All
Advocacy
https://cdn.prod.website-files.com/638f893112c6eac0e46ac576/6453f688a121567c7026889d_PPTA%20Supports%20AB%20392%20Nazarian.pdf
No results found